Correction: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy$dstudy protocol of the TRADE-hypo trial

Saved in:
Bibliographic Details
Main Authors: Bozorgmehr, Farastuk (Author) , Chung, Inn (Author) , Christopoulos, Petros (Author) , Krisam, Johannes (Author) , Schneider, Marc (Author) , Brückner, Lena Marie (Author) , Müller, Daniel Wilhelm (Author) , Thomas, Michael (Author) , Rieken, Stefan (Author)
Format: Article (Journal)
Language:English
Published: 10 August 2023
In: BMC cancer
Year: 2023, Volume: 23, Issue: 1, Pages: 1
ISSN:1471-2407
DOI:10.1186/s12885-023-11270-x
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12885-023-11270-x
Get full text
Author Notes:Farastuk Bozorgmehr, Inn Chung, Petros Christopoulos, Johannes Krisam, Marc A. Schneider, Lena Brückner, Daniel Wilhelm Mueller, Michael Thomas and Stefan Rieken
Description
Item Description:Gesehen am 23.07.2024
Physical Description:Online Resource
ISSN:1471-2407
DOI:10.1186/s12885-023-11270-x